Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study

Journal of Clinical Oncology

Volumn 15, Issue 1, 1997, Pages 297-303

  Crino L ^a   Scagliotti, G ^a   Marangolo, M ^a   Figoli, F ^a   Clerici, M ^a   De Marinis, F ^a   Salvati, F ^a   Cruciani, G ^a   Dogliotti, L ^a   Pucci, F ^a   Paccagnella, A ^a   Adamo, V ^a   Altavilla, G ^a   Incoronato, P ^a   Trippetti, M ^a   Mosconi, A M ^a   Santucci, A ^a   Sorbolini, S ^a   Oliva, C ^a   Tonato, M ^a  

^a Policlinico Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MALE; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 17344384670     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.1.297     Document Type: Article

References (23)

1. Ihde DC: Chemotherapy of lung cancer. N Engl J Med 327:1434-1441, 1992
2. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311:899-909, 1995
3. Lilenbaum R, Green M: Novel chemotherapeutic agents in the treatment of non-small cell lung cancer. J Clin Oncol 11:1391-1403, 1993
4. Hertel LW, Boder GB, Kroin JS, et al: Evaluation of the antitumor activity of gemcitabine. Cancer Res 50:4417-4422, 1990
5. Heinemann V, Hertel LW, Grindey GB, et al: Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-D-arabinofuranosylcytosine. Cancer Res 48:4024-4031, 1988
6. Huang P, Chubb S, Hertel L, et al: Action of 2-2 difluorodeoxycytidine on DNA synthesis. Cancer Res 51:6110-6117, 1991
7. Fossella FV, Lippman S, Tarassof P, et al: Phase I/II study of gemcitabine, an active agent for advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 14:371, 1995 (abstr 1144)
8. Kaye SB: Gemcitabine: Current status of phase I and II trials. J Clin Oncol 12:1527-1531, 1994
9. 2780 human ovarian cancer cell line is schedule dependent. Proc Am Assoc Cancer Res 35:1950, 1994 (abstr)
10. BraaKhuis BJM, Ruiz van Haperen VWT, Bergman AM, et al: Preclinical in vivo evaluation of the combination of 2,3 difluorodeoxycytidine (dFdC, gemcitabine) and cisplatin (CDDP). Ann Oncol 5:82, 1994 (abstr) (suppl 5)
11. Anderson H, Lund B, Bach F, et al: Single-agent activity of weekly gemcitabine in advanced non-small-cell-lung cancer: A phase II study. J Clin Oncol 12:1821-1826, 1994
12. Abratt RP, Bezwoda W, Falkson G, et al: Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study. J Clin Oncol 12:1535-1540, 1994
13. Shepherd F, Cormier Y, Burkes R, et al: Modified continual reassessment methodology (mCRM): A superior way to assess toxicity in a phase I study of gemcitabine and cisplatin for non-small cell lung cancer (N.S.C.L.C.). Proc Am Soc Clin Oncol 14:358, 1995 (abstr 1090)
14. Steward W, Dunlop D, Cameron D, et al: Phase I/II study of cisplatin in combination with gemcitabine in non-small cell lung cancer. Proc Am Soc Clin Oncol 14:351, 1995 (abstr 1064)
15. Abratt R, Bezwoda W, Goedhals L, et al: Gemcitabine and cisplatin for advanced non small cell lung cancer. Proc Am Soc Clin Oncol 15:380, 1996 (abstr 1136)
16. Peters GJ, Bergman AM, Ruiz van Haperen VWT, et al: Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol 22:72-79, 1995 (suppl 11)
17. Abbruzzese JL, Frost P: Studies on the mechanism of the synergistic interaction between 2′deoxy-5 azacytidine and cisplatin. Cancer Chemother Pharmacol 30:31-36, 1992
18. Shewach DS, Hahn TM, Chang E, et al: Metabolism of 2′2′ difluoro 2′ deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 54:3218-3223, 1994
19. Bergman A, Ruiz van Haperen VWT, Weerman G, et al: Synergistic interaction between cisplatin and gemcitabine in vitro. Clin Cancer Res 2:521-530, 1996
20. Sandler A, Ansari R, McClean J, et al: Gemcitabine plus cisplatin in non-small cell lung cancer: A phase II study. Eur J Cancer 31A:S225, 1995 (abstr) (suppl 5)
21. Crinò L, Tonato M, Darwish S, et al: A randomized trial of three cisplatin-containing regimens in advanced non-small cell lung cancer. Cancer Chemother Pharmacol 26:52-56, 1990
22. Ruckdeschel JC, Finkelstein DM, Ettinger DS, et al: A randomized trial of the four most active regimens for metastatic non-small cell lung cancer. J Clin Oncol 4:14-22, 1986
23. Crinò L, Clerici M, Figoli F, et al: Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.). Ann Oncol 6:347-353, 1995